[
    [
        {
            "time": "",
            "original_text": "港股医药股普跌复星医药(2196.HK)跌超2%",
            "features": {
                "keywords": [
                    "港股",
                    "医药股",
                    "复星医药",
                    "普跌"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "港股医药股普跌复星医药(2196.HK)跌超2%",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "【行情】港股医药股集体大跌，百济神州跌近8%，复星医药跌超6%，再鼎医药跌5%，康希诺跌超3% 连续下跌",
            "features": {
                "keywords": [
                    "港股",
                    "医药股",
                    "百济神州",
                    "复星医药",
                    "再鼎医药",
                    "康希诺",
                    "集体大跌",
                    "连续下跌"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【行情】港股医药股集体大跌，百济神州跌近8%，复星医药跌超6%，再鼎医药跌5%，康希诺跌超3% 连续下跌",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "港股医药股多数下跌，百济神州跌6.8%",
            "features": {
                "keywords": [
                    "港股",
                    "医药股",
                    "百济神州",
                    "多数下跌"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "港股医药股多数下跌，百济神州跌6.8%",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 6,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "中信证券：料复星医药旗下复必泰疫苗本季内地获批",
            "features": {
                "keywords": [
                    "中信证券",
                    "复星医药",
                    "复必泰疫苗",
                    "内地获批"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "中信证券：料复星医药旗下复必泰疫苗本季内地获批",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "交易异动！复星医药：近3个交易日上涨23.75%，无未披露的重大事项",
            "features": {
                "keywords": [
                    "交易异动",
                    "复星医药",
                    "上涨",
                    "23.75%",
                    "无重大事项"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "交易异动！复星医药：近3个交易日上涨23.75%，无未披露的重大事项",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]